Indermal Kanchan Bai Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.49 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit 55.61%
(FY 2023)
- Ebitda 55.39%
(FY 2023)
- Net Worth -214.24%
(FY 2023)
- Total Assets 136.10%
(FY 2023)
About Indermal Kanchan Bai
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹14.49 Cr.
Lalita Jain and Sumeet Jain serve as directors at the Company.
- CIN/LLPIN
U85300MP2021PTC054692
- Company No.
054692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Dhar, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indermal Kanchan Bai?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalita Jain  | Director | 30-Jan-2021 | Current |
| Sumeet Jain | Director | 30-Jan-2021 | Current |
Financial Performance and Corporate Structure Insights of Indermal Kanchan Bai.
Indermal Kanchan Bai Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 55.61% increase in profit. The company's net worth observed a substantial decline by a decrease of 214.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indermal Kanchan Bai?
Unlock access to Indermal Kanchan Bai's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Acharya Rajendra Health Services Private LimitedActive 7 years 5 monthsLalita Jain is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Mar 2024 | ₹1.14 Cr | Open |
Others Creation Date: 30 Sep 2021 | ₹13.35 Cr | Open |
How Many Employees Work at Indermal Kanchan Bai?
Unlock and access historical data on people associated with Indermal Kanchan Bai, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indermal Kanchan Bai, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indermal Kanchan Bai's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
